Martin Shkreli Barred From Drug Industry and Must Repay $64.6 Millionnews2022-01-14T23:25:06+00:00January 14th, 2022|The New York Times|
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstaclesnews2021-12-21T02:08:14+00:00December 21st, 2021|The New York Times|
Biden Touts Legislation to Reform Prescription Drug Pricesnews2021-12-06T23:07:57+00:00December 6th, 2021|The New York Times|
Inflation and Retirement: How to Protect Your Savingsnews2021-11-19T19:25:10+00:00November 19th, 2021|The New York Times|
AstraZeneca Says it Will Start Profiting From its Vaccinenews2021-11-13T05:15:23+00:00November 13th, 2021|The New York Times|
Democrats Choosing Less Risky Path on Drug Pricesnews2021-11-06T07:00:07+00:00November 6th, 2021|The New York Times|
Democrats Reach Deal to Control Drug Prices in Billnews2021-11-02T23:14:56+00:00November 2nd, 2021|The New York Times|
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Votenews2021-11-01T23:14:05+00:00November 1st, 2021|The New York Times|
This May Be Democrats’ Best Chance to Lower Drug Pricesnews2021-10-27T15:01:32+00:00October 27th, 2021|The New York Times|
Democrats’ Campaign to Control Drug Prices Nears Collapsenews2021-10-21T21:49:36+00:00October 21st, 2021|The New York Times|
